IPPS Rule Lowers FY 2005 Add-On Threshold, Denies InFuse Application
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to lower the cost threshold for new devices to qualify for technology "add-on" payments under the IPPS assumes that the number of applications for the additional reimbursement will remain sparse
You may also be interested in...
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
New Tech “Add-On” Payments Sought By Hospital On Behalf Of Firms
CardiacAssist hopes to obtain new technology "add-on" inpatient reimbursement for its TandemHeart percutaneous vascular assist device (PVAD), which will be used in an estimated 200 cardiogenic shock cases in 2005
First Device Qualifies For Add-On Payment; CMS Retains Proposed Threshold
The device industry's hopes to reduce the Centers for Medicare & Medicaid Services' new technology "add-on" payment threshold are riding on a provision in the House's "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1)